SCHEMBL8038852

SCHEMBL8038852

O=C(Nc1cccnc1)c1c[nH]c2c1C(=O)CCCC2

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
NAMPT P43490 5/20 0.47
HTT P42858 1/20 0.47
CYP11B2 P19099 4/20 0.47
CYP11B1 P15538 1/20 0.46
LMNA P02545 2/20 0.46
HIF1A Q16665 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
KCNMA1 Q12791 1/20 0.44
SORT1 Q99523 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386449 0.98 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL8049526 0.85 KDM4E (0.42) ALDH1A1KDM4ENAMPTHTTNPC1
SCHEMBL7360053 0.85 CFTR (0.49) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6162613 0.84 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL7384705 0.83 BUB1 (0.43) ALDH1A1KDM4ENAMPTHTTKCNMA1
SCHEMBL4897236 0.83 CFTR (0.49) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6770247 0.82 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6303008 0.81 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6770578 0.81 BUB1 (0.50) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6092190 0.81 BUB1 (0.47) ALDH1A1MEN1KMT2AKDM4ENAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096887-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. NEUROGEN CORPORATION (US) 2000-08-01 US claimed
US-6096887-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. NEUROGEN CORPORATION (US) 2000-08-01 US disclosed
WO-1998002433-A1 CERTAIN FUSED PYRROLECARBOXAMIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1998-01-22 WO disclosed